These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30115642)

  • 1. Computational modeling and confirmation of leukemia-associated minor histocompatibility antigens.
    Lansford JL; Dharmasiri U; Chai S; Hunsucker SA; Bortone DS; Keating JE; Schlup IM; Glish GL; Collins EJ; Alatrash G; Molldrem JJ; Armistead PM; Vincent BG
    Blood Adv; 2018 Aug; 2(16):2052-2062. PubMed ID: 30115642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT.
    Olsen KS; Jadi O; Dexheimer S; Bortone DS; Vensko SP; Bennett S; Tang H; Diiorio M; Saran T; Dingfelder D; Zhu Q; Wang Y; Haiman CA; Pooler L; Sheng X; Webb A; Pasquini MC; McCarthy PL; Spellman SR; Weimer E; Hahn T; Sucheston-Campbell L; Armistead PM; Vincent BG
    Blood Adv; 2023 May; 7(9):1635-1649. PubMed ID: 36477467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
    Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data.
    Armistead PM; Liang S; Li H; Lu S; Van Bergen CA; Alatrash G; St John L; Hunsucker SA; Sarantopoulos S; Falkenburg JH; Molldrem JJ
    PLoS One; 2011; 6(8):e23217. PubMed ID: 21858034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity.
    Stumpf AN; van der Meijden ED; van Bergen CA; Willemze R; Falkenburg JH; Griffioen M
    Blood; 2009 Oct; 114(17):3684-92. PubMed ID: 19706888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell Transplantation.
    Story CM; Wang T; Bhatt VR; Battiwalla M; Badawy SM; Kamoun M; Gragert L; Brown V; Baxter-Lowe LA; Marsh SGE; Gadalla SM; Schetelig J; Mytilineos J; Miklos D; Waller EK; Kuxhausen M; Spellman S; Lee S; Paczesny S; Lansford JL; Vincent BG; Riches ML; Armistead PM;
    Transplant Cell Ther; 2021 Jul; 27(7):591-599. PubMed ID: 33882342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Analysis of HLA-presentation of Non-synonymous Recipient Mismatches Indicates Effect on the Risk of Chronic Graft-vs.-Host Disease After Allogeneic HSCT.
    Ritari J; Hyvärinen K; Koskela S; Niittyvuopio R; Nihtinen A; Salmenniemi U; Putkonen M; Volin L; Kwan T; Pastinen T; Itälä-Remes M; Partanen J
    Front Immunol; 2019; 10():1625. PubMed ID: 31379830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.
    Woolfrey A; Klein JP; Haagenson M; Spellman S; Petersdorf E; Oudshoorn M; Gajewski J; Hale GA; Horan J; Battiwalla M; Marino SR; Setterholm M; Ringden O; Hurley C; Flomenberg N; Anasetti C; Fernandez-Vina M; Lee SJ
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):885-92. PubMed ID: 20870028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor.
    Balduini CL; Frassoni F; Noris P; Klersy C; Iannone AM; Bacigalupo A; Giorgiani G; Di Pumpo M; Locatelli F
    Br J Haematol; 2001 Sep; 114(4):951-3. PubMed ID: 11564091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor T cells administered over HLA class II barriers mediate antitumor immunity without broad off-target toxicity in a NOD/scid mouse model of acute leukemia.
    Stevanović S; Nijmeijer BA; van Schie ML; Salvatori DC; Maas S; Griffioen M; Falkenburg JH
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):867-75. PubMed ID: 23500532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL.
    Matte-Martone C; Liu J; Jain D; McNiff J; Shlomchik WD
    Blood; 2008 Apr; 111(7):3884-92. PubMed ID: 18223170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel minor histocompatibility antigens responsible for graft-versus-leukemia (GVL) effect on chronic myeloid leukemia: usefulness of determining the clonotype of T cells associated with GVL effect after donor leukocyte infusion.
    Nakao S
    Int J Hematol; 2002 Aug; 76 Suppl 1():274-6. PubMed ID: 12430863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation.
    Gallardo D; Aróstegui JI; Balas A; Torres A; Caballero D; Carreras E; Brunet S; Jiménez A; Mataix R; Serrano D; Vallejo C; Sanz G; Solano C; Rodríguez-Luaces M; Marín J; Baro J; Sanz C; Román J; González M; Martorell J; Sierra J; Martín C; de la Cámara R; Grañena A;
    Br J Haematol; 2001 Sep; 114(4):931-6. PubMed ID: 11564088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells.
    Young FM; Campbell A; Emo KL; Jansson J; Wang PY; Jordan CT; Mullen CA
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):622-30. PubMed ID: 18489987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction.
    van der Zouwen B; Kruisselbrink AB; Frederik Falkenburg JH; Jedema I
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):760-9. PubMed ID: 24607556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience.
    Delia M; Pastore D; Mestice A; Carluccio P; Perrone T; Gaudio F; Ricco A; Sgherza N; Albano F; Specchia G
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):495-9. PubMed ID: 23200706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic disparities of 11 minor histocompatibility antigens (mHAs) in HLA-matched unrelated allogeneic hematopoietic SCT.
    Markiewicz M; Siekiera U; Karolczyk A; Szymszal J; Helbig G; Wojnar J; Dzierzak-Mietla M; Kyrcz-Krzemien S
    Bone Marrow Transplant; 2009 Feb; 43(4):293-300. PubMed ID: 18850018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of a newly identified HLA-A24-restricted minor histocompatibility antigen epitope derived from BCL2A1, ACC-1, in patients receiving HLA genotypically matched unrelated bone marrow transplant.
    Nishida T; Akatsuka Y; Morishima Y; Hamajima N; Tsujimura K; Kuzushima K; Kodera Y; Takahashi T
    Br J Haematol; 2004 Mar; 124(5):629-35. PubMed ID: 14871250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens.
    Fuchs KJ; Honders MW; van der Meijden ED; Adriaans AE; van der Lee DI; Pont MJ; Monajemi R; Kielbasa SM; 't Hoen PAC; van Bergen CAM; Falkenburg JHF; Griffioen M
    Front Immunol; 2020; 11():659. PubMed ID: 32362897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.